Status:
COMPLETED
Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Post Menopausal
Breast Cancer
Eligibility:
FEMALE
Brief Summary
There are different types of hormonal therapy medicines for the treatment of hormone-receptor-positive breast cancer. The purpose of this study is to determine the evolution of two types of hormonal t...
Eligibility Criteria
Inclusion
- Post-menopausal patients with surgically treated breast cancer who started adjuvant hormonal therapy between January 2006 and December 2006 or between January 2008 and December 2008
- Documented evidence of the way adjuvant hormonal treatment was initiated.
Exclusion
- Pre- or peri-menopausal patients with surgically treated breast cancer who started adjuvant hormonal therapy
- Patients already enrolled in clinical studies aimed at investigating hormone therapies
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
515 Patients enrolled
Trial Details
Trial ID
NCT00884143
Start Date
July 1 2009
End Date
January 1 2010
Last Update
April 20 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aviano, PN, Italy
2
Research Site
Trento, Italy
3
Research Site
Verona, Italy